Physician profile
Philip Keith
NPI 1346402153
$1,965.59
in general payments reported to CMS, 2019-2025
12 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.76 · 2020: $1,517 · 2021: $73.06 · 2022: $16.53 · 2024: $92.75 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Bct, INC. | $1,500.00 | 2020 | |
| Abiomed | $136.66 | 2024-2025 | Impella |
| Getinge USA Sales, LLC | $104.06 | 2025 | Cardiohelp |
| Astrazeneca Pharmaceuticals LP | $48.57 | 2019-2021 | |
| Inari Medical, INC. | $29.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $28.10 | 2019-2020 | |
| Csl Behring | $24.76 | 2024 | Hizentra |
| Astellas Pharma US INC | $24.12 | 2019 | |
| Livanova USA, INC. | $22.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.53 | 2022 | |
| Bio Products Laboratory USA, INC. | $16.51 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Keith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.